107 related articles for article (PubMed ID: 21937259)
1. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors.
Helal Tel A; Fadel MT; El-Thobbani AK; El-Sarhi AM
Oral Oncol; 2012 Feb; 48(2):120-4. PubMed ID: 21937259
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cell cycle proteins and hMSH2 in actinic cheilitis and lip cancer.
Lopes ML; de Oliveira DH; Sarmento DJ; Queiroz LM; Miguel MC; da Silveira ÉJ
Arch Dermatol Res; 2016 Apr; 308(3):165-71. PubMed ID: 26842232
[TBL] [Abstract][Full Text] [Related]
3. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
6. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma.
Jessri M; Dalley AJ; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):74-82. PubMed ID: 25446502
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy.
Fernandes AM; Ramos-Jorge ML; Cardoso SV; Loyola AM; Mesquita RA; Aguiar MC
J Oral Pathol Med; 2008 Oct; 37(9):543-8. PubMed ID: 18331286
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma.
Souza LR; Fonseca-Silva T; Pereira CS; Santos EP; Lima LC; Carvalho HA; Gomez RS; Guimarães AL; De Paula AM
Histopathology; 2011 Feb; 58(3):352-60. PubMed ID: 21323960
[TBL] [Abstract][Full Text] [Related]
10. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of mismatch proteins in carcinogenesis of the lower lip.
Sarmento DJ; de Almeida WL; Miguel MC; Queiroz LM; Godoy GP; da Cruz MC; da Silveira EJ
Histopathology; 2013 Sep; 63(3):371-7. PubMed ID: 23865379
[TBL] [Abstract][Full Text] [Related]
12. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
13. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
[TBL] [Abstract][Full Text] [Related]
14. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
Bathi RJ; Prabhat
Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
[TBL] [Abstract][Full Text] [Related]
15. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
17. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
18. Analysis of hMSH2 mismatch repair protein expression in dysplasia, carcinoma in situ and invasive squamous cell carcinoma of the vocal folds.
Hussein MR; Aref EE; Yassen DG; Ramadan MO
Cancer Invest; 2009 Jan; 27(1):38-46. PubMed ID: 19160096
[TBL] [Abstract][Full Text] [Related]
19. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma.
Kusama K; Okutsu S; Takeda A; Himiya T; Kojima A; Kidokoro Y; Chu L; Iwanari S; Kudo I; Moro I
J Pathol; 1996 Apr; 178(4):415-21. PubMed ID: 8691320
[TBL] [Abstract][Full Text] [Related]
20. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
Ichikawa M; Ishii K; Nakajima T; Mogi K
J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
